scholarly journals 1 DEVELOPMENT OF LYMPHOMAS IN HUMAN ORIGIN IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY (SCID): ROLE OF EPSTEIN-BARR VIRUS (EBV) AND INTERLEUKIN-6 (IL-6)

1991 ◽  
Vol 30 (6) ◽  
pp. 628-628
Author(s):  
David Nadal ◽  
Boris Albini ◽  
Erika Schläpfer ◽  
Pearay L Ogra
2003 ◽  
Vol 6 (5) ◽  
pp. 449-457 ◽  
Author(s):  
Hector Monforte-Muñoz ◽  
Neena Kapoor ◽  
Jorge Albores Saavedra

The occurrence of smooth muscle neoplasms and lymphoproliferative disorders in immunocompromised patients is well recognized. We report the case of an 8-year-old girl with adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID) status post-bone marrow transplant (BMT), in whom Epstein-Barr virus (EBV) was detected in innumerable leiomyomas involving the gallbladder (leiomyomatosis), and multifocal leiomyomas in liver, spleen, pancreas, intestinal tract, and lung. The leiomyomas of the gallbladder, liver, spleen, and lung were asymptomatic, while those located in the colon became clinically manifest by recurrent lower intestinal hemorrhage. The patient also developed extensive EBV-associated polymorphic lymphoproliferative disorder (PTLD) in nodal and extranodal sites. In addition, there were pulmonary and gastric adenovirus and small and large intestine cryptosporidum infections. Our case appears to be the first example of leiomyomatosis of the gallbladder coexisting with multifocal leiomyomas of the liver, spleen, pancreas, intestinal tract, and lung, as well as EBV-derived lymphoproliferative disorder in a young girl with ADA-deficient SCID. Awareness of the pattern of involvement and of the coexistence of benign leiomyomatous proliferations with lymphoproliferative disorder is of value when gallbladder, pancreatic, biliary tree, lung, and intestinal lesions become clinically manifest in these patients. The demonstration of EBV infection in both leiomyomata and the PTLD suggests a common pathogenesis that may have therapeutic and prognostic implications.


1998 ◽  
Vol 64 (3) ◽  
pp. 205-212 ◽  
Author(s):  
Babak Salimi ◽  
Maurice R.G O'Gorman ◽  
Daina Variakojis ◽  
Moshe Bendet ◽  
Malka Newman ◽  
...  

1994 ◽  
Vol 36 (4) ◽  
pp. 456-460 ◽  
Author(s):  
Ben Z Katz ◽  
Babak Salimi ◽  
Urmil Saini ◽  
James G Mcnamara ◽  
Richard Eisen

2019 ◽  
Vol 12 (5) ◽  
pp. e227715 ◽  
Author(s):  
Rawia Albar ◽  
Moaffaq Mahdi ◽  
Fawaz Alkeraithe ◽  
Khalid Nawaf Almufarriji

Severe combined immunodeficiency (SCID) is an extremely rare disease caused by a disruption in the forkhead box N1 (FOXN1) gene, with an incidence of <1 per 1 000 000 live births. We report a boy aged 4 months who presented with a history of fever for 3 weeks and enlarged lymph nodes. The fever was associated with dry cough and runny nose. On physical examination, we noted oral thrush, generalised lymphadenopathy, nail dystrophy and alopecia. Flow cytometry of lymph node biopsy showed high-grade B-cell lymphoma. In addition, Epstein-Barr virus (EBV) infection was documented by PCR. The diagnosis of SCID was made by genetic testing, which revealed a homozygous variant of the FOXN1 gene. The variant was confirmed with Sanger sequencing. Management of EBV infection and lymphoma was initiated; unfortunately, the patient passed away on day 45 of hospitalisation.


2021 ◽  
Vol 2021 ◽  
pp. 1-4
Author(s):  
Moriah Forster ◽  
Timothy Moran ◽  
Anne Beaven ◽  
Timothy Voorhees

Zeta-chain-associated protein kinase 70 (ZAP-70) plays an integral role in the T-cell antigenic receptor complex. A deficiency of this kinase leads to a phenotype of severe combined immunodeficiency, while hypomorphic mutations of the kinase lead to more mild immunodeficiency phenotypes. We present a case of a 21-year-old patient with lymphadenopathy who was found to have Epstein–Barr virus (EBV) lymphoproliferative disease (LPD) and the development of hemophagocytic lymphohistiocytosis (HLH). On further workup, the patient was ultimately found to have a homozygous intrionic mutation in ZAP-70. This is a novel ZAP-70 mutation (c.1623 + 5G > A) associated with combined immunodeficiency and an EBV-positive LPD. A primary immunodeficiency is important to consider in a young, otherwise healthy patient presenting with an EBV-positive LPD.


Sign in / Sign up

Export Citation Format

Share Document